Volt Lithium to Commission Mobile Direct Lithium Extraction Unit in North Dakota's Bakken Region
Volt's modular, rapidly deployable DLE technology is gaining strong interest from industry partners.
Share
' Wellspring and the State of North Dakota are excited to commence field operations with Volt in North Dakota in the second half of June,' commented Mark Watson, President and CEO of Wellspring. ' Volt is the only DLE company that the State Of North Dakota has funded to date ', added Mr. Watson. 'Based upon the successful lithium extraction results at Volt's R&D Facility in Calgary, both groups have full confidence Volt's proprietary lithium extraction unit will be successful in the field.'
The upcoming name change to LibertyStream Infrastructure Partners Inc., reflects the Company's ongoing strategy to partner with key oilfield infrastructure players in the US to extract lithium, a valuable critical mineral, from the significant streams of produced water associated with oil and gas production.
Key Highlights:
Proprietary Technology and Process adapts to multiple brine chemistries, driving Volt's Expansion to the Bakken in North Dakota
Strategically positioned in North America's two largest oil-producing basins (Permian and Bakken).
Permian potential: up to 170,000 tonnes of Lithium Carbonate Equivalent (LCE) annually.
Bakken potential: up to 50,000 tonnes of LCE annually, nearly 3x higher lithium concentration compared to the Permian.
Building active inventory of lithium chloride and converting to high-purity lithium carbonate for potential off takers.
Deployed, scaled and optimized North America's largest operational DLE system (10,000+ barrels/day) within six months of initial deployment.
Proprietary Technology and Process Driving Volt's Expansion to the Bakken in North Dakota
Volt's proprietary operating system has been built to partner with existing salt-water disposal ('SWD') operators in oilfields across the US and the Company's proprietary extraction compound (the 'Media') is tailored to extract lithium from oilfield brines. This partnership model reduces capital and operating costs compared to developing a traditional greenfield lithium extraction facility. By integrating our DLE units with existing infrastructure, Volt accelerates its path to production and enhances project economics in several key ways:
Capital Savings: We eliminate the need for costly and time-intensive greenfield development, including drilling new wells, extensive land acquisition, and building new pipeline networks. Our units tie directly into the partner's SWD facilities; and
Operating Savings: We tap into a continuous stream of lithium-rich brine that is already being brought to the surface as part of daily oilfield operations.
The combination of Volt's proprietary operating system and Media has facilitated the Company's significant growth from lab scale production in 2024 at its Research and Development Facility ('R&D Facility') in Calgary, Alberta to its field operating system in the Permian Basin capable of processing 10,000 barrels of brine per day in 2025.
With the Bakken field unit, Volt aims to demonstrate that its proprietary, modular DLE process can capture value across both high‑volume, lower‑grade brines and higher‑concentration resources—showcasing basin‑agnostic versatility and the potential for improved project economics in multiple North American basins.
Strategic Significance: North American Lithium Leadership
Volt Lithium now holds strategic footholds in North America's two most prolific onshore oil-producing basins—the Permian in Texas and New Mexico, and the Bakken in North Dakota. Together, these basins represent over 60% of total U.S. onshore oil output, providing significant opportunities for lithium extraction from extensive lithium-rich produced water volumes.
The Permian Basin alone generates approximately 19 million barrels per day of produced water at lithium concentrations averaging around 30 ppm, translating to a conservative 170,000 tonnes per annum ("tpa") of potential LCE.
The Williston Basin Bakken production ranges from 1.6 million to 2 million barrels of produced water per day. Internal lab tests on Bakken brine samples show lithium concentrations reaching 90 ppm —nearly three times Permian grades, suggesting potential production of ~50 000 tpa LCE.
Commercial Readiness and Market Engagement
Volt is building an inventory of lithium chloride from its Permian Basin operations and has initiated converting this inventory into lithium carbonate, achieving purity levels suitable for premium-specification offtake agreements. Samples are being distributed to potential offtake partners to facilitate commercial partnerships and validate product specifications.
Operational Milestones & Scalability
In September 2024, Volt deployed its first DLE field unit in the Permian Basin, subsequently scaling up to its Generation 5 unit by February 2025. This rapid scaling resulted in North America's largest operational DLE system, capable of processing over 10,000 barrels per day of produced water.
The upcoming Bakken mobile deployment represents further lateral expansion, validating the modular technology's adaptability across basins and showcasing its potential for rapid replication and scaling.
North Dakota Unit Field Deployment, High-Level Stakeholder & Government Engagement
Volt is in the final stages of assembling its mobile Field Unit for deployment and commissioning in North Dakota in the second half of June 2025. Volt's field trial will be processing brine from the Bakken formation. The Bakken represents the second largest producer of brine in the continental USA, processing up to 2 million barrels of brine per day at lithium concentrations up to 90 ppm. While conducting the field trial, Volt and Wellspring Hydro look forward to hosting representatives from the following key stakeholder groups:
State of North Dakota Representatives and Leadership
North Dakota State Senators
North Dakota Department of Commerce Leaders
North Dakota Trade and Financial Leaders
Key Industry Stakeholders
These stakeholders, along with interested investors, will participate in site visits during both commissioning and operational phases, gaining firsthand insights into the technology's scalability and strategic impact.
CEO Commentary
'Volt's modular, rapidly deployable DLE technology is gaining strong interest from industry partners. Volt's deployment of a second unit into the Bakken demonstrates the technology is capable of adapting to multiple types of oilfields and varying grades of lithium concentrations, positioning the Company to meet growing market demand and expand across key American basins.'
— Alex Wylie, President & CEO of Volt Lithium
About Volt Lithium
Volt is a lithium development and technology company aiming to be one of North America's first commercial producers of lithium carbonates from oilfield brine. Our strategy is to generate value for shareholders by leveraging management's hydrocarbon experience to deploy our proprietary DLE technology directly into existing oil and gas infrastructure, thereby reducing capital costs, lowering risks and supporting the world's clean energy transition. With four differentiating pillars, and a proprietary Direct Lithium Extraction (' DLE ') technology and process, Volt's innovative approach to development is focused on generating the highest lithium recoveries with lowest costs, positioning us for future commercialization. We are committed to operating efficiently and with transparency across all areas of the business staying sharply focused on creating long-term, sustainable shareholder value. Investors and/or other interested parties may sign up for updates about the Company's continued progress on its website: https://voltlithium.com/.
Contact Information
Forward Looking Statements
This news release includes certain 'forward-looking statements' and 'forward-looking information' within the meaning of applicable Canadian securities laws. When used in this news release, the words 'anticipate', 'believe', 'estimate', 'expect', 'target', 'plan', 'forecast', 'may', 'will', 'would', 'could', 'schedule' and similar words or expressions, identify forward-looking statements or information. Statements, other than statements of historical fact, may constitute forward-looking information and include, without limitation, information with respect to the terms of the operational milestone, Volume Scale-up. Extraction Time Improvements and Continuous Processing vs Batch Processing, the deployment of the Field Unit in the Permian Basin, the production of battery grade lithium by the Field Unit, and the commercial production of lithium from oilfield brine. With respect to the forward-looking information contained in this press release, the Company has made numerous assumptions. While the Company considers these assumptions to be reasonable, these assumptions are inherently subject to significant uncertainties and contingencies and may prove to be incorrect. Additionally, there are known and unknown risk factors which could cause the Company's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained herein including those known risk factors outlined in the Company's annual information form for the year ended June 30, 2024 and (final) short form base shelf prospectus dated July 20, 2023. All forward-looking information herein is qualified in its entirety by this cautionary statement, and the Company disclaims any obligation to revise or update any such forward-looking information or to publicly announce the result of any revisions to any of the forward-looking information contained herein to reflect future results, events or developments, except as required by law.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
42 minutes ago
- Yahoo
Hemostemix Closes $469,366 Private Placement
Calgary, Alberta--(Newsfile Corp. - July 4, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") announces that the TSX Venture Exchange ("TSXV") conditionally approved the Company's previously disclosed non-brokered private placement (the "Offering") in the amount of CAD $469,366. The Offering consisted of the issuance of 3,911,385 Common Shares at a price of CAD $0.12. As per TSXV Policy 4.1, the investor is arm's length to the Company and is not a Related Party to the Company at the time of disclosure. The use of proceeds will be allocated to general working capital purposes, supporting the Company's continuing operational expenses and business development activities. The Company confirms that there is no material fact or material change about the Company that has not been generally disclosed. All securities issued in connection with the Offering are subject to a four-month hold period from the closing date under applicable Canadian securities laws, in addition to such other restrictions as may apply under applicable securities laws of jurisdictions outside Canada. ABOUT HEMOSTEMIXHemostemix is an autologous stem cell therapy platform company, founded in 2003. A winner of the World Economic Forum Technology Pioneer Award, the Company has developed, patented, is scaling and selling autologous (patient's own) blood-based stem cell therapy, VesCell (ACP-01). Hemostemix has completed seven clinical studies of 318 subjects and published its results in ten peer reviewed publications. ACP-01 is safe, clinically relevant and statistically significant as a treatment for peripheral arterial disease, chronic limb threatening ischemia, non ischemic dilated cardiomyopathy, ischemic cardiomyopathy, congestive heart failure, and angina. Hemostemix completed its Phase II clinical trial for chronic limb threatening ischemia and published its results in the Journal of Biomedical Research & Environmental Science. As compared to a five year mortality rate of 60% in the CLTI patient population, UBC and U of T reported to the 41st meeting of vascular surgeons: 0% mortality, cessation of pain, wound healing in 83% of patients followed for up to 4.5 years, as a midpoint result. For more information, please visit For further information, please contact: Thomas Smeenk, President, CEO & Co-Founder: EM: tsmeenk@ / PH: 905-580-4170 Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined under the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Forward-Looking Information: This news release contains "forward-looking information" within the meaning of applicable Canadian securities legislation. All statements, other than statements of historical fact, included herein are forward-looking information. In particular, this news release contains forward-looking information in relation to the Closing of a non brokered private placement, in furtherance of sales in Florida of VesCell (ACP-01), and the commercialization of ACP-01 via the sale of compassionate treatments under Florida SB 1768. There can be no assurance that such forward-looking information will prove to be accurate. Actual results and future events could differ materially from those anticipated in such forward-looking information. This forward-looking information reflects Hemostemix's current beliefs and is based on information currently available to Hemostemix and on assumptions Hemostemix believes are reasonable. These assumptions include, but are not limited to: the underlying value of Hemostemix and its Common Shares; the successful resolution of any litigation that Hemostemix is pursuing or defending (the "Litigation"); the results of ACP-01 research, trials, studies and analyses, including the analysis being equivalent to or better than previous research, trials or studies; the receipt of all required regulatory approvals for research, trials or studies; the level of activity, market acceptance and market trends in the healthcare sector; the economy generally; consumer interest in Hemostemix's services and products; competition and Hemostemix's competitive advantages; and, Hemostemix obtaining satisfactory financing to fund Hemostemix's operations including any research, trials or studies, and any Litigation. Forward-looking information is Subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Hemostemix to be materially different from those expressed or implied by such forward-looking information. Such risks and other factors may include, but are not limited to: the ability of Hemostemix to complete clinical trials, complete a satisfactory analyses and file the results of such analyses to gain regulatory approval of a phase II or phase III clinical trial of ACP-01; potential litigation Hemostemix may face; general business, economic, competitive, political and social uncertainties; general capital market conditions and market prices for securities; delay or failure to receive board or regulatory approvals; the actual results of future operations including the actual results of future research, trials or studies; competition; changes in legislation affecting Hemostemix; the timing and availability of external financing on acceptable terms; long-term capital requirements and future developments in Hemostemix's markets and the markets in which it expects to compete; lack of qualified, skilled labour or loss of key individuals; and risks related to the COVID-19 pandemic including various recommendations, orders and measures of governmental authorities to try to limit the pandemic, including travel restrictions, border closures, non-essential business closures service disruptions, quarantines, self-isolations, shelters-in-place and social distancing, disruptions to markets, disruptions to economic activity and financings, disruptions to supply chains and sales channels, and a deterioration of general economic conditions including a possible national or global recession or depression; the potential impact that the COVID-19 pandemic may have on Hemostemix which may include a decreased demand for the services that Hemostemix offers; and a deterioration of financial markets that could limit Hemostemix's ability to obtain external financing. A description of additional risk factors that may cause actual results to differ materially from forward-looking information can be found in Hemostemix's disclosure documents on the SEDAR website at Although Hemostemix has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. Readers are cautioned that the foregoing list of factors is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking information as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Forward-looking information contained in this news release is expressly qualified by this cautionary statement. The forward-looking information contained in this news release represents the expectations of Hemostemix as of the date of this news release and, accordingly, it is Subject to change after such date. However, Hemostemix expressly disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law. To view the source version of this press release, please visit Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Hamilton Spectator
an hour ago
- Hamilton Spectator
Consolidated Lithium Metals announces exposure of a new Li-bearing pegmatite at its Preissac Project and closes financing
TORONTO, July 04, 2025 (GLOBE NEWSWIRE) — Consolidated Lithium Metals Inc. (TSXV: CLM | FRA: Z36) ('CLM' or the 'Company') is pleased to announce the commencement of its summer 2025 exploration campaign at its Preissac Project (Fig. 1). As part of the program, a trench measuring 100 meters in length, and 30 meters in width has been excavated in the area of a previously identified lithium (Li) soil anomaly. The trench successfully exposed an 18-meter-wide pegmatite body, confirming the presence of promising mineralized structures at surface. Following the excavation, a channel sampling program was completed. In total, 25 channel samples were collected, prepared, and logged in detail. All samples, including QA/QC samples, were sent to Impact Global Solutions Inc., ('IGS Canada') for analysis. Furthermore, several previous Li showings were soil/bio-sampled again along lines across the predicted strike of the pegmatites related to the anomalies. Figure 1 – Trenching/Channel sampling location at Preissac-Lacorne property Figure 2 – Newly exposed pegmatite (Dyke 1) Figure 3 – Newly exposed pegmatite (Dyke 1) Figure 4 – Pictures of channel samples with local centimetric spodumene was observed (Dyke 2) Figure 5 – Pictures of the trench and channel samples (Dyke 1) Preissac Property | Bio/Soil Sampling Program The bio/soil sampling program, completed in April and June of 2025, used a 15m-by-15m grid to cover lithium and copper soil anomalies detected on CLM's Preissac-Lacorne property during a property wide soil sampling campaign completed in 2022. In total, 279 bio and 252 soil samples were collected, prepared, and logged in detail. All samples, including QA/QC samples, were sent to IGS Canada for analysis. Figure 6 – CLM 2025 Exploration | Channel/Soil/Bio Sampling | Preissac-Lacorne Property Exploration Program Specifics About Soil Sampling Soil samples were collected from the B-horizon of the soil profile in plastic bags shipping to the laboratory for geochemical analysis. The analyses were undertaken by IGS Canada in Delson, Quebec. Upon arrival at the laboratory, the samples were dried, weighed, crushed, and split into subsamples of which one 250g subsample was pulverized to allow 85% of the material to pass through a 75-micron sieve. The sieved subsample was digested in acid and analyzed using ICP-MS, ICP-OES, and SPF. The Company implemented QA/QC procedures to ensure the validity of the sampling by using a series of field duplicates in each batch of samples sent for analysis. A review of the field duplicates indicate that the soil sample results are likely reasonably precise and accurate. IGS Canada is an independent ISO/IEC 17025:2017 accredited facility (#889) by the Standards Council of Canada. Dr. Andreas Rompel, Vice President Exploration, commented: 'We are very excited about the newly discovered pegmatite and we intend to continue to expose it further. This is merely the first step in our exploration efforts at Preissac, which remains the least explored project area within CLM. Additional trenching is expected to follow to investigate the soil anomalies identified in previous surveys.' Financing Close CLM also announces today that it has closed its previously announced non-brokered private placement financing of units (each, a 'Unit') at a price of $0.01 per Unit for gross proceeds of up to $300,000 (the 'Offering'). The Company previously closed a tranche of the Offering on April 2, 2025, pursuant to which the Company issued 21,000,000 Units for gross proceeds of $210,000; no further tranches will be closed pursuant to the Offering. For more information about the first tranche and the Offering, please see the Company's press releases dated April 2, 2025, and February 14, 2025, April 11, 2025, May 12, 2025, and June 12, 2025, respectively, each of which is available under the Company's SEDAR+ profile at . Qualified Person The scientific and technical information contained herein has been reviewed and approved by Alexandr Beloborodov, the Company's independent geologist consultant, who is a 'Qualified Person' as defined in National Instrument 43-101 – Standards of Disclosure for Mineral Projects . About Consolidated Lithium Metals Inc. Consolidated Lithium Metals Inc. is a Canadian junior mining exploration company trading under the symbol 'CLM' on the TSX Venture Exchange and 'Z36' on the Frankfurt Stock Exchange. The Company is focused on the acquisition, exploration, production, and development of mining properties. The Company's properties are in Quebec, Canada, primarily in the spodumene-bearing pegmatites of the La Corne Batholith, around North American Lithium Inc.'s Quebec lithium mine. For more information: Rene Bharti, Vice President Corp. Dev. Email | info@ Phone: +1 (647) 965 2173 Website: Cautionary Statements This press release contains 'forward-looking information' within the meaning of applicable Canadian securities legislation. Forward-looking information includes, but is not limited to, statements with respect to the scope, objectives, and expected results of the Company's summer 2025 exploration program and the Company's ability to execute its business plan. Generally, forward-looking information can be identified by the use of forward-looking terminology such as 'plans', 'expects' or 'does not expect', 'is expected', 'budget', 'scheduled', 'estimates', 'forecasts', 'intends', 'anticipates' or 'does not anticipate', or 'believes', or variations of such words and phrases or statements that certain actions, events or results 'may', 'could', 'would', 'might' or 'will be taken', 'occur' or 'be achieved'. Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of CLM to be materially different from those expressed or implied by such forward-looking information, including but not limited to: receipt of necessary approvals; general business, economic, competitive, political and social uncertainties; future mineral prices and market demand; accidents, labour disputes and shortages and other risks of the mining industry. Although CLM has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. CLM does not undertake to update any forward-looking information, except in accordance with applicable securities laws. NEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE. Photos accompanying this announcement are available at:
Forbes
an hour ago
- Forbes
This Lazy Take On US Debt Could Cause You To Miss A 14% Dividend
United States fifty dollar bill with the United States Capitol building close up Well, that didn't last long. A few months ago, all we heard from the mainstream media is that the 'sell America' trend was going to stick around for a long time. Nowadays, we're still hearing that. But one corner of the market—closed-end funds (CEFs)—is telling us something interesting: That investors are starting to turn their attention back to the US. That's given us an opportunity to front-run this quiet shift now, while it's still early, with some high-yield CEFs trading at attractive discounts. In a second, I'll walk you through the signal we're getting from two of the biggest US-focused CEFs—one holding stocks, the other corporate bonds. First, though, let's talk about what the real data says about one of the biggest fears that's been driving the so-called 'sell America' theme—US debt. US Debt Ratio Current This chart shows how much US households pay to manage their debt, as a percentage of disposable income. It's the main evidence supporting the argument that fears about US economic stability are warranted. To be fair, this chart does show a jump—about 10% in the last three years. In other words, yes, Americans' debt costs are higher than they were in 2022. That's a sure sign the US consumer is tapped out, right? If this all sounds familiar, it's because it's the same story the press pushed in 2022, with headlines like 'Consumer Debt Surges at Fastest Pace in 15 Years.' Three years later, the US economy remains strong. So maybe it's going to finally falter now? That's what the Wall Street Journal has been saying. In March, it published a story titled, 'Consumers Keep Bailing Out the Economy. Now They Might Be Maxed Out,' and another headlined: 'Recession Fears Stoke Concerns Americans Are Overstretched.' Now let's look at a chart that starts to dispel this fear and tell us the real story here. US Debt Ratio Historic Household debt payments definitely rose from their all-time low in 2021. Now they've leveled off at around 5.5% of disposable income. That's about where they were in the early 2010s. Today's level is also far below the average in the 1980s, 1990s and 2000s. US Debt Not The Problem… In other words, Americans are not maxed out. In fact, their household-debt levels are quite low. According to IMF data, US households are less indebted than those in much of Europe and Asia, as well as Australia and Canada, both of which are places thought to be fiscally responsible. Household Debt, Global At current levels of American disposable income (which is among the highest in the world) and debt levels (one of the lowest), the average US household is paying about $282 per month on its debt. That's hardly a lot of money for most people! It's also worth pointing out that the average American family's net worth had risen to $192,700 by 2022 (when the Federal Reserve did its latest survey), fully recovering from the Great Recession. There's a direct line between this financial improvement and the S&P 500's world-beating long-term performance: SPY Total Returns Which brings me back to that indication CEFs are giving us that investors may finally be catching on to the strength of the US consumer. To get at that, let's look at a major corporate-bond CEF, the PIMCO Dynamic Income Fund (PDI), and the Nuveen S&P 500 Dynamic Overwrite Fund (SPXX). As SPXX's name says, it holds the S&P 500, but it also sells call options—a low-risk way to support its dividend. In a June 9 article on our Contrarian Outlook website, we talked about how SPXX and PDI work together to give an investor a nicely diversified 'mini-portfolio' of stocks and bonds. We also identified an international fund, the Clough Global Opportunities Fund (GLO), as a less-effective way to diversify. With CEFs, we have two measures of performance: total return based on net asset value (NAV, or the value of a fund's underlying portfolio) and total return based on market price. These can be different, with NAV a better measure of the fund's portfolio management and market price a measure of the fund's overall performance, subject to investor whim. When we look at the total NAV returns of the US-focused funds in the past year (SPXX, in orange below, and PDI, in blue), we see that they exceed that of the more global fund, GLO (in purple), by a fair margin: US Outperforms But if we pivot away from NAV for a moment and look at GLO's total price return, we see that the global fund, GLO, has a far better performance, returning 15% (in orange below), far higher than the 6.4% return on its NAV (in purple) and indeed ahead of SPXX. GLO Total Returns Here's what's really happening: Market demand for this fund is outpacing the fundamentals by a lot. That's causing GLO's discount to NAV to narrow (it's now 11.7%). Over time, investors will likely realize that fundamentals are underperforming market demand here and that, when compared to SPXX's 7.6% yield and PDI's 14% payout, both funds are better contenders than GLO to deliver strong total returns alongside a rotation back into America. And that means there's still time to profit from these two funds and avoid the growing possibility of underperforming by holding GLO, as that fund's market-price gains run ahead of its fundamentals, potentially setting it up for a fall. In short, the 'pivot back to America' trade is wide open in CEF-land, where big (and often monthly paid) dividends are also on the table—if you stick to the data and ignore media fearmongering. Michael Foster is the Lead Research Analyst for Contrarian Outlook. For more great income ideas, click here for our latest report 'Indestructible Income: 5 Bargain Funds with Steady 10% Dividends.' Disclosure: none
